Suivre
Charles Whittaker
Charles Whittaker
Autres nomsCharlie Whittaker, Charles F. Whittaker
Adresse e-mail validée de imperial.ac.uk
Titre
Citée par
Citée par
Année
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
N Ferguson, D Laydon, G Nedjati Gilani, N Imai, K Ainslie, M Baguelin, ...
Imperial College COVID-19 Response Team, 2020
49202020
Estimates of the severity of coronavirus disease 2019: a model-based analysis
R Verity*, LC Okell*, I Dorigatti*, P Winskill*, C Whittaker*, N Imai, ...
The Lancet infectious diseases 20 (6), 669-677, 2020
46292020
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Nature 584 (7820), 257-261, 2020
4028*2020
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries
PGT Walker*, C Whittaker*, OJ Watson*, M Baguelin, P Winskill, A Hamlet, ...
Science 369 (6502), 413-422, 2020
1623*2020
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
NR Faria*, TA Mellan*, C Whittaker*, IM Claro*, DS Candido*, S Mishra*, ...
Science 372 (6544), 815-821, 2021
1558*2021
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
1388*2021
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ...
Nature 584 (7821), 425-429, 2020
10112020
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
AB Hogan*, BL Jewell*, E Sherrard-Smith*, JF Vesga*, OJ Watson*, ...
The Lancet Global Health 8 (9), e1132-e1141, 2020
858*2020
Reduction in mobility and COVID-19 transmission
P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ...
Nature communications 12 (1), 1-9, 2021
5682021
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
LF Buss, CA Prete Jr, CMM Abrahim, A Mendrone Jr, T Salomon, ...
Science 371 (6526), 288-292, 2021
5572021
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ...
Science 374 (6570), 995-999, 2021
3012021
The FLC Locus: A Platform for Discoveries in Epigenetics and Adaptation
C Whittaker, C Dean
Annual Review of Cell and Developmental Biology 33 (1), 2017
2762017
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ...
The Lancet Infectious Diseases 20 (12), 1381-1389, 2020
248*2020
Response to COVID-19 in South Korea and implications for lifting stringent interventions
A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ...
BMC medicine 18, 1-12, 2020
1942020
Global disparities in SARS-CoV-2 genomic surveillance
AF Brito, E Semenova, G Dudas, GW Hassler, CC Kalinich, MUG Kraemer, ...
Nature communications 13 (1), 7003, 2022
1822022
The potential public health consequences of COVID-19 on malaria in Africa
E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson, C Whittaker, ...
Nature medicine 26 (9), 1411-1416, 2020
1782020
State-level tracking of COVID-19 in the United States
HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ...
Nature communications 11 (1), 6189, 2020
1712020
Subnational analysis of the initial phase of the COVID-19 epidemic in Brazil
TA Mellan, H Hoeltgebaum, S Mishra, C Whittaker, I Hawryluk, A Gandy, ...
2023 ICLR First Workshop on {\textquotedblleft} Machine Learning {\&} Global …, 2023
161*2023
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment
KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ...
Wellcome Open Research 5, 2020
1482020
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
NF Brazeau, R Verity, S Jenks, H Fu, C Whittaker, P Winskill, I Dorigatti, ...
Communications medicine 2 (1), 54, 2022
142*2022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20